Merck Serono's Erbitux Recognized by American Society of Clinical Oncology as a 2009 Major Cancer Advance as First SCCHN Treatment to Improve Survival in 30 Years
11/16/2009 9:37:37 AM
More...
|
ZymoGenetics, Inc. (ZGEN) (JOBS) Says Merck Serono Discontinues MS Trials
9/28/2009 6:27:01 AM
More...
|
Lpath, Inc. and Merck Serono Extend ASONEP(TM) Collaboration
9/24/2009 1:36:59 PM
More...
|
Merck Serono Fertility Drug May Reduce Hot Flashes in Study
9/17/2009 7:24:21 AM
More...
|
ZymoGenetics, Inc. (ZGEN) (JOBS), Merck Serono Arthritis Drug Hits Roadblock
9/11/2009 7:12:43 AM
More...
|
Merck Serono to Present New Data at ECCO/ESMO Oncology Congress Showcasing Leadership in Personalized Cancer Care
9/10/2009 9:25:26 AM
More...
|
Lpath, Inc. Achieves Merck Serono Milestone
8/24/2009 10:46:30 AM
More...
|
Merck Serono and MSM Protein Technologies Establish Drug Discovery Collaboration Targeted to Complex Cell Surface Receptors
7/30/2009 9:08:02 AM
More...
|
BioSeek, Inc. and Merck Serono Extend 2008 Agreement
6/10/2009 8:55:59 AM
More...
|
Poxel SAS Set up to Find Innovative Solutions for Metabolic Diseases Management
5/28/2009 11:22:48 AM
More...
|
|